Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liver SBRT with ICI in Metastatic NSCLC
NCT05430009Phase 1Recruiting
- Sponsor
- VA Ann Arbor Healthcare System
- Start
- Jun 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by VA Ann Arbor Healthcare System. Primary endpoint: Percentage of patients who receive all fractions of radiotherapy as planned at 0.5 years. Started Jun 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05430009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05430009.